Craft
  • Home
  •  / Recursion Pharmaceuticals
Recursion Pharmaceuticals

Recursion Pharmaceuticals

Revenue

$10.2 M

FY, 2021

Market Capitalization

$1.8 B

2022-09-20

Recursion Pharmaceuticals Summary

Company summary

Overview
Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology. The company uses high-throughput genetic manipulation to model diseases in multiple human cell types.
Type
Public
Founded
2013
HQ
Salt Lake City, UT, US | view all locations
Website
https://www.recursion.com/
Cybersecurity rating
Sectors

Key people

  • Chris Gibson

    Chris Gibson, Co-Founder and CEO

  • Heather Kirkby

    Heather Kirkby, Chief People Officer

  • Michael Secora

    Michael Secora, Chief Financial Officer

  • Mason Victors

    Mason Victors, Chief Product Officer

LocationsView all

1 location detected

  • Salt Lake City, UT HQ

    United States

    41 S Rio Grande St

Recursion Pharmaceuticals Financials

Summary financials

Revenue (Q2, 2022)
$7.7M
Cash (Q2, 2022)
$453.9M
Enterprise value
$1.4B

Footer menu